Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01269307 · ClinicalTrials.gov registry record · NA
Combination Ketamine and Propofol vs Propofol for Emergency Department Sedation: A Prospective Randomized Trial
A NA study, sponsored by University of Utah.
- Completed
- Registry status
- NA
- Development phase
- 99
- Enrollment target
NCT01269307: Completed NA study, sponsored by University of Utah.
NCT01269307 is a NA study that has completed, run by University of Utah. The registered enrollment target is 99 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01269307, a NA study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- NA
- Development phase
- 99 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if procedural sedation utilizing a 1:1 mixture of propofol and ketamine is equivalent in complications, patient and physician satisfaction, post-procedure pain level, and procedural outcome to propofol sedation alone.
Primary Outcome
The use of any: Adjunctive airway device (nasopharyngeal airway (NPA)/oropharyngeal airway (OPA), Jaw thrust or other airway maneuver., Use of Bag Valve Mask (BVM) for ventilation and reversal medications (i.e. Narcan).
Interventions
- PROCEDURE 1:1 ketamine-propofol mixture sedation
- PROCEDURE Propofol Sedation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2010-06 |
| Est. Completion | 2012-12 |
| Phase | NA |
What the finished NCT01269307 record still lists
NCT01269307 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 99 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which 1:1 ketamine-propofol mixture sedation is the first listed.
NCT01269307 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01269307 about?
NCT01269307 is a clinical study titled "Combination Ketamine and Propofol vs Propofol for Emergency Department Sedation: A Prospective Randomized Trial". The purpose of this study is to determine if procedural sedation utilizing a 1:1 mixture of propofol and ketamine is equivalent in complications, patient and physician satisfaction, post-procedure pain level, and procedural outcome to propofol sedation alone.
What is the current status of trial NCT01269307?
This trial is currently completed. It is a NA study. The enrollment target is 99 participants. The study started on 2010-06. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01269307?
The interventions under investigation include: 1:1 ketamine-propofol mixture sedation (PROCEDURE), Propofol Sedation (PROCEDURE).
Who is sponsoring clinical trial NCT01269307?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01269307's enrollment target sits among peer trials
99 920th of 2000 higher than 1,079 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03965234 · 99 participants · Phase 1
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
- NCT04022616 · 99 participants
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
- NCT04042844 · 99 participants · Phase 2
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
- NCT04143724 · 99 participants · Phase 2
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia